Clinical Trial Update: Renin and Renal Biomarker Response to Angiotensin II [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports results evaluating renin and renal biomarker responses to Angiotensin II in patients with septic shock and acute kidney injury…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Septic Shock

Drugs mentioned

• Giapreza (Angiotensin II)

Snippet

Sponsor: Alexander Flannery | Conditions: Septic Shock, Acute Kidney Injury | Phase 4 | Status: COMPLETED | Results posted: 2024-09-04